Open Access

Audience questions and close

Topic: Treatment
Sponsored by Boehringer Ingelheim and Eli Lilly and Company

Congress Presentation

4 more presentations in this session

Welcome and introduction

Speaker: Professor I. Pina (Philadelphia, US)


2023 heart failure guideline recommendations: where do we stand?

Speaker: Doctor A. Bayes Genis (Badalona, ES)


What value do SGLT2 inhibitors offer to patients hospitalised for heart failure?

Speaker: Professor J. Teerlink (San Francisco, US)


Starting SGLT2 inhibitors in practice: considerations for implementation in the hospital setting

Speaker: Doctor M. Kosiborod (Kansas City, US)


Access the full session

Practical guidance to implement heart failure treatment with SGLT2 inhibitors in the hospital setting

Speakers: Professor I. Pina, Doctor A. Bayes Genis, Professor J. Teerlink, Doctor M. Kosiborod

About the event


ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb